Annual Shareholders Equity
$1.93 M
-$14.64 M-88.33%
December 31, 2023
Summary
- As of February 7, 2025, VRPX annual stockholders equity is $1.93 million, with the most recent change of -$14.64 million (-88.33%) on December 31, 2023.
- During the last 3 years, VRPX annual shareholders equity has risen by +$6.15 million (+145.88%).
- VRPX annual shareholders equity is now -94.84% below its all-time high of $37.48 million, reached on December 31, 2021.
Performance
VRPX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$2.05 M
+$742.90 K+26.58%
September 30, 2024
Summary
- As of February 7, 2025, VRPX quarterly stockholders equity is -$2.05 million, with the most recent change of +$742.90 thousand (+26.58%) on September 30, 2024.
- Over the past year, VRPX quarterly shareholders equity has dropped by -$8.56 million (-131.54%).
- VRPX quarterly shareholders equity is now -104.95% below its all-time high of $41.46 million, reached on September 30, 2021.
Performance
VRPX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VRPX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.3% | -131.5% |
| 3 y3 years | +145.9% | -105.0% |
| 5 y5 years | +262.2% | -105.0% |
VRPX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.8% | at low | -105.5% | +26.6% |
| 5 y | 5-year | -94.8% | +145.9% | -105.0% | +51.3% |
| alltime | all time | -94.8% | +145.9% | -105.0% | +51.3% |
Virpax Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$2.05 M(-26.6%) |
| Jun 2024 | - | -$2.79 M(+130.3%) |
| Mar 2024 | - | -$1.21 M(-162.7%) |
| Dec 2023 | $1.93 M(-88.3%) | $1.93 M(-70.3%) |
| Sep 2023 | - | $6.51 M(-47.1%) |
| Jun 2023 | - | $12.30 M(-19.0%) |
| Mar 2023 | - | $15.20 M(-8.3%) |
| Dec 2022 | $16.58 M | $16.58 M(-14.7%) |
| Sep 2022 | - | $19.43 M(-27.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $26.92 M(-17.3%) |
| Mar 2022 | - | $32.56 M(-13.1%) |
| Dec 2021 | $37.48 M(-989.1%) | $37.48 M(-9.6%) |
| Sep 2021 | - | $41.46 M(+450.2%) |
| Jun 2021 | - | $7.54 M(-21.2%) |
| Mar 2021 | - | $9.56 M(-326.7%) |
| Dec 2020 | -$4.22 M(+54.3%) | -$4.22 M(+9.6%) |
| Sep 2020 | - | -$3.85 M(+40.8%) |
| Dec 2019 | -$2.73 M(+129.1%) | -$2.73 M |
| Dec 2018 | -$1.19 M | - |
FAQ
- What is Virpax Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual shareholders equity year-on-year change?
- What is Virpax Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Virpax Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of VRPX is $1.93 M
What is the all time high annual shareholders equity for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual stockholders equity is $37.48 M
What is Virpax Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, VRPX annual stockholders equity has changed by -$14.64 M (-88.33%)
What is Virpax Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of VRPX is -$2.05 M
What is the all time high quarterly shareholders equity for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly stockholders equity is $41.46 M
What is Virpax Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, VRPX quarterly stockholders equity has changed by -$8.56 M (-131.54%)